SGRY
Surgery Partners, Inc.
Company overview
- Market capitalization
- $1.92B
- Employees
- 16,000
- Latest publication
- 2026-09-29
About Surgery Partners, Inc.
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Financial statements
Income Quarterly
| Metric | Q1 20252025-03-31 · USD | Q3 20172017-09-30 · USD |
|---|---|---|
| Total Revenue | 776,000,000USD | 282,682,000USD |
| Cost Of Revenue | 614,100,000USD | 201,394,000USD |
| Gross Profit | 161,900,000USD | 81,288,000USD |
| Selling General Administrative | 36,000,000USD | 35,841,000USD |
| Unclassified Operating Expenses | 64,000,000USD | — |
| Total Operating Expenses | 100,000,000USD | 308,000,000USD |
| Operating Income | 61,900,000USD | 42,848,000USD |
| Interest Expense | 62,200,000USD | 26,475,000USD |
| Net Interest Income | -62,200,000USD | — |
| Income Before Tax | -300,000USD | 12,640,000USD |
| Income Tax Expense | 37,400,000USD | -1,694,000USD |
| Tax Provision | 0USD | — |
| Net Income | -37,700,000USD | 14,334,000USD |
| Net Income From Continuing Ops | -300,000USD | -2,300,000USD |
| Ebit | 61,900,000USD | 20,220,999USD |
| Ebitda | 98,200,000USD | 31,220,999USD |
| Depreciation And Amortization | 36,300,000USD | 11,000,000USD |
| Reconciled Depreciation | 36,300,000USD | 11,000,000USD |
| Total Other Income Expense Net | -62,200,000USD | -17,638,000USD |
| Minority Interest | -37,400,000USD | 15,305,000USD |
| Research Development | — | 0USD |
| Selling And Marketing Expenses | — | 272,159,000USD |
| Discontinued Operations | — | 0USD |
| Net Income Applicable To Common Shares | — | -2,300,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 8,042,100,000USD | 8,242,000,000USD | 7,946,600,000USD | 7,954,800,000USD | 7,949,200,000USD | 7,890,000,000USD | 7,534,400,000USD | 7,488,600,000USD |
| Intangible Assets | 39,800,000USD | 41,000,000USD | 43,000,000USD | 41,400,000USD | 45,200,000USD | 45,700,000USD | 46,100,000USD | 52,200,000USD |
| Other Current Assets | 196,300,000USD | 212,000,000USD | 227,200,000USD | 204,800,000USD | 186,600,000USD | 182,400,000USD | 189,100,000USD | 194,700,000USD |
| Total Liab | 4,560,800,000USD | 4,715,200,000USD | 4,393,600,000USD | 4,375,900,000USD | 4,362,700,000USD | 4,254,800,000USD | 3,986,100,000USD | 3,870,200,000USD |
| Total Stockholder Equity | 1,688,000,000USD | 1,712,900,000USD | 1,729,500,000USD | 1,748,300,000USD | 1,740,400,000USD | 1,789,700,000USD | 1,896,500,000USD | 1,952,400,000USD |
| Other Current Liab | 270,500,000USD | 264,800,000USD | 267,100,000USD | 248,800,000USD | 260,900,000USD | 273,300,000USD | 265,700,000USD | 246,100,000USD |
| Common Stock | 1,300,000USD | 1,300,000USD | 1,300,000USD | 1,300,000USD | 1,300,000USD | 1,300,000USD | 1,300,000USD | 1,300,000USD |
| Capital Stock | 1,300,000USD | 1,300,000USD | 1,300,000USD | 1,300,000USD | 1,300,000USD | 1,300,000USD | 1,300,000USD | 1,300,000USD |
| Retained Earnings | -851,100,000USD | -815,200,000USD | -800,200,000USD | -777,500,000USD | -775,000,000USD | -737,300,000USD | -628,800,000USD | -597,100,000USD |
| Good Will | 5,205,200,000USD | 5,194,600,000USD | 5,091,600,000USD | 5,098,600,000USD | 5,126,200,000USD | 5,068,000,000USD | 4,815,400,000USD | 4,806,300,000USD |
| Cash | 182,300,000USD | 239,900,000USD | 203,400,000USD | 250,100,000USD | 229,300,000USD | 269,500,000USD | 221,800,000USD | 213,500,000USD |
| Cash And Short Term Investments | 182,300,000USD | 239,900,000USD | 203,400,000USD | 250,100,000USD | 229,300,000USD | 269,500,000USD | 221,800,000USD | 213,500,000USD |
| Total Current Assets | 1,082,500,000USD | 1,150,700,000USD | 1,102,200,000USD | 1,105,300,000USD | 1,074,600,000USD | 1,119,400,000USD | 1,035,800,000USD | 1,012,500,000USD |
| Total Current Liabilities | 581,700,000USD | 615,500,000USD | 586,000,000USD | 573,300,000USD | 569,400,000USD | 624,400,000USD | 575,200,000USD | 551,800,000USD |
| Net Debt | 3,845,700,000USD | 3,784,900,000USD | 3,667,800,000USD | 3,628,400,000USD | 3,645,800,000USD | 3,433,900,000USD | 3,297,500,000USD | 3,215,500,000USD |
| Short Term Debt | 142,600,000USD | 142,000,000USD | 144,300,000USD | 149,600,000USD | 143,500,000USD | 142,400,000USD | 138,700,000USD | 131,700,000USD |
| Short Long Term Debt | 100,400,000USD | 99,300,000USD | 103,000,000USD | 110,000,000USD | 103,900,000USD | 101,400,000USD | 97,300,000USD | 92,400,000USD |
| Short Long Term Debt Total | 4,028,000,000USD | 4,024,800,000USD | 3,871,200,000USD | 3,878,500,000USD | 3,875,100,000USD | 3,703,400,000USD | 3,519,300,000USD | 3,429,000,000USD |
| Long Term Debt | 3,613,500,000USD | 3,602,900,000USD | 3,460,600,000USD | 3,465,200,000USD | 3,446,900,000USD | 3,268,900,000USD | 3,094,200,000USD | 3,039,700,000USD |
| Long Term Investments | 225,400,000USD | 234,000,000USD | 229,400,000USD | 220,200,000USD | 218,600,000USD | 215,400,000USD | 214,800,000USD | 227,100,000USD |
| Net Receivables | 603,400,000USD | 602,200,000USD | 579,300,000USD | 563,100,000USD | 570,600,000USD | 579,100,000USD | 542,900,000USD | 523,400,000USD |
| Inventory | 100,500,000USD | 96,600,000USD | 92,300,000USD | 87,300,000USD | 88,100,000USD | 88,400,000USD | 82,000,000USD | 80,900,000USD |
| Accounts Payable | 168,600,000USD | 208,700,000USD | 174,600,000USD | 174,900,000USD | 165,000,000USD | 208,700,000USD | 170,800,000USD | 174,000,000USD |
| Property Plant Equipment Net | 1,416,400,000USD | 1,442,600,000USD | 1,439,700,000USD | 1,451,200,000USD | 1,428,800,000USD | 1,384,000,000USD | 1,302,000,000USD | 1,272,700,000USD |
| Property Plant Equipment Gross | 2,102,400,000USD | 2,093,800,000USD | 2,059,400,000USD | 2,040,000,000USD | 2,015,800,000USD | 1,937,900,000USD | 1,860,800,000USD | 1,791,800,000USD |
| Accumulated Other Comprehensive Income | -10,500,000USD | -13,800,000USD | -14,400,000USD | -13,300,000USD | -11,799,999USD | 4,800,000USD | 10,500,000USD | 37,100,000USD |
| Common Stock Shares Outstanding | 128,367,000shares | 127,209,000shares | 126,932,000shares | 126,980,000shares | 126,602,000shares | 126,209,000shares | 126,172,000shares | 126,134,000shares |
| Non Current Assets Total | 6,959,600,000USD | 7,091,300,000USD | 6,844,400,000USD | 6,849,500,000USD | 6,874,600,000USD | 6,770,600,000USD | 6,498,599,999USD | 6,476,100,000USD |
| Non Current Liabilities Total | 3,979,100,000USD | 4,099,700,000USD | 3,807,600,000USD | 3,802,600,000USD | 3,793,300,000USD | 3,630,400,000USD | 3,410,900,000USD | 3,318,400,000USD |
| Non Current Liabilities Other | 41,600,000USD | 41,200,000USD | 38,100,000USD | 36,300,000USD | 34,600,000USD | 30,200,000USD | 30,300,000USD | 21,100,000USD |
| Non Currrent Assets Other | 72,800,000USD | 56,800,000USD | 40,700,000USD | 38,100,000USD | 55,800,000USD | 57,500,000USD | 41,099,999USD | 36,000,000USD |
| Net Working Capital | 500,800,000USD | 535,200,000USD | 516,200,000USD | 532,000,000USD | 505,200,000USD | 495,000,000USD | 460,600,000USD | 460,700,000USD |
| Unclassified Current Liabilities | -100,400,000USD | -99,300,000USD | -103,000,000USD | -110,000,000USD | -103,900,000USD | -101,400,000USD | -97,300,000USD | -213,400,000USD |
| Unclassified Non Current Liabilities | 324,000,000USD | 455,600,000USD | 308,900,000USD | 301,100,000USD | 311,800,000USD | 331,300,000USD | 286,400,000USD | 257,600,000USD |
| Unclassified Equity | 2,547,000,000USD | 2,539,300,000USD | 2,541,500,000USD | 2,536,500,000USD | 2,524,599,999USD | 2,519,600,000USD | 2,512,200,000USD | 2,509,800,000USD |
| Unclassified Non Current Assets | — | 122,300,000USD | — | — | — | — | 79,199,999USD | 81,800,000USD |
| Other Assets | — | — | — | — | — | — | 1USD | — |
| Current Deferred Revenue | — | — | — | — | — | — | — | 121,000,000USD |
| Short Term Investments | — | — | — | — | — | — | — | 4,200,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 8,242,000,000USD | 7,890,000,000USD | 6,876,700,000USD | 6,682,100,000USD | 6,117,600,000USD | 5,413,200,000USD | 5,018,900,000USD | 4,676,267,000USD |
| Intangible Assets | 41,000,000USD | 45,700,000USD | 54,800,000USD | 42,300,000USD | 43,700,000USD | 46,900,000USD | 47,300,000USD | 54,293,000USD |
| Other Current Assets | 212,000,000USD | 182,400,000USD | 127,500,000USD | 110,400,000USD | 64,900,000USD | 45,000,000USD | 59,600,000USD | 44,509,000USD |
| Total Liab | 4,715,200,000USD | 4,254,800,000USD | 3,514,800,000USD | 3,399,200,000USD | 3,817,800,000USD | 3,789,800,000USD | 3,319,500,000USD | 4,676,267,000USD |
| Total Stockholder Equity | 1,712,900,000USD | 1,789,700,000USD | 1,987,200,000USD | 1,998,200,000USD | 1,089,000,000USD | 550,100,000USD | 691,800,000USD | 404,640,000USD |
| Other Current Liab | 264,800,000USD | 273,300,000USD | 240,300,000USD | 239,300,000USD | 247,000,000USD | 243,200,000USD | 208,100,000USD | 210,407,000USD |
| Common Stock | 1,300,000USD | 1,300,000USD | 1,300,000USD | 1,300,000USD | 900,000USD | 500,000USD | 500,000USD | 489,000USD |
| Capital Stock | 1,300,000USD | 1,300,000USD | 1,300,000USD | 1,300,000USD | 900,000USD | 435,000,000USD | 395,500,000USD | 359,835,000USD |
| Retained Earnings | -815,200,000USD | -737,300,000USD | -569,200,000USD | -557,300,000USD | -502,700,000USD | -431,800,000USD | -315,700,000USD | -247,022,000USD |
| Good Will | 5,194,600,000USD | 5,068,000,000USD | 4,326,000,000USD | 4,137,100,000USD | 3,911,800,000USD | 3,468,000,000USD | 3,402,400,000USD | 3,382,846,000USD |
| Cash | 239,900,000USD | 269,500,000USD | 195,900,000USD | 282,900,000USD | 389,900,000USD | 317,900,000USD | 92,700,000USD | 184,308,000USD |
| Cash And Short Term Investments | 239,900,000USD | 269,500,000USD | 195,900,000USD | 282,900,000USD | 389,900,000USD | 317,900,000USD | 92,700,000USD | 184,308,000USD |
| Total Current Assets | 1,150,700,000USD | 1,119,400,000USD | 895,000,000USD | 921,000,000USD | 946,100,000USD | 801,500,000USD | 525,500,000USD | 588,322,000USD |
| Total Current Liabilities | 615,500,000USD | 624,400,000USD | 523,000,000USD | 493,400,000USD | 536,800,000USD | 556,800,000USD | 398,100,000USD | 349,299,000USD |
| Net Debt | 3,784,900,000USD | 3,433,900,000USD | 2,865,700,000USD | 2,646,800,000USD | 2,904,600,000USD | 2,879,000,000USD | 2,808,400,000USD | 2,291,953,000USD |
| Short Term Debt | 142,000,000USD | 142,400,000USD | 110,900,000USD | 99,300,000USD | 100,500,000USD | 103,600,000USD | 93,300,000USD | 55,600,000USD |
| Short Long Term Debt | 99,300,000USD | 101,400,000USD | 73,300,000USD | 62,800,000USD | 60,400,000USD | 64,400,000USD | 56,000,000USD | 55,552,000USD |
| Short Long Term Debt Total | 4,024,800,000USD | 3,703,400,000USD | 3,061,600,000USD | 2,929,700,000USD | 3,294,500,000USD | 3,196,900,000USD | 2,901,100,000USD | 2,476,261,000USD |
| Long Term Debt | 3,602,900,000USD | 3,268,900,000USD | 2,701,800,000USD | 2,559,000,000USD | 2,878,400,000USD | 2,792,400,000USD | 2,524,700,000USD | 2,270,898,000USD |
| Long Term Investments | 234,000,000USD | 215,400,000USD | 184,100,000USD | 190,300,000USD | 88,700,000USD | 90,300,000USD | 93,200,000USD | 78,477,000USD |
| Net Receivables | 602,200,000USD | 579,100,000USD | 496,400,000USD | 456,300,000USD | 430,200,000USD | 382,200,000USD | 326,900,000USD | 316,142,000USD |
| Inventory | 96,600,000USD | 88,400,000USD | 75,200,000USD | 71,400,000USD | 61,100,000USD | 56,400,000USD | 46,300,000USD | 43,363,000USD |
| Accounts Payable | 208,700,000USD | 208,700,000USD | 171,800,000USD | 151,600,000USD | 124,900,000USD | 100,200,000USD | 96,700,000USD | 83,292,000USD |
| Property Plant Equipment Net | 1,442,600,000USD | 1,384,000,000USD | 1,224,000,000USD | 1,155,700,000USD | 953,800,000USD | 854,700,000USD | 821,000,000USD | 426,286,000USD |
| Property Plant Equipment Gross | 2,093,800,000USD | 1,937,900,000USD | 1,678,400,000USD | 1,530,000,000USD | 1,226,100,000USD | 854,700,000USD | 821,000,000USD | 426,286,000USD |
| Accumulated Other Comprehensive Income | -13,800,000USD | 4,800,000USD | 57,500,000USD | 76,200,000USD | -31,500,000USD | -61,000,000USD | -50,700,000USD | -22,446,000USD |
| Common Stock Shares Outstanding | 127,209,000shares | 126,122,000shares | 125,613,000shares | 91,952,000shares | 72,427,000shares | 48,776,000shares | 48,280,000shares | 48,027,875shares |
| Non Current Assets Total | 7,091,300,000USD | 6,770,600,000USD | 5,981,700,000USD | 5,761,100,000USD | 5,171,500,000USD | 4,611,700,000USD | 4,493,400,000USD | 4,087,945,000USD |
| Non Current Liabilities Total | 4,099,700,000USD | 3,630,400,000USD | 2,991,800,000USD | 2,905,800,000USD | 3,281,000,000USD | 3,233,000,000USD | 2,921,400,000USD | 2,542,085,000USD |
| Non Current Liabilities Other | 41,200,000USD | 30,200,000USD | 41,100,000USD | 75,400,000USD | 87,000,000USD | 139,700,000USD | 113,600,000USD | 121,376,000USD |
| Non Currrent Assets Other | 56,800,000USD | 57,500,000USD | 103,300,000USD | 144,200,000USD | 59,100,000USD | 27,000,000USD | 30,800,000USD | 36,850,000USD |
| Net Working Capital | 535,200,000USD | 495,000,000USD | 372,000,000USD | 427,600,000USD | 409,300,000USD | 244,700,000USD | 127,400,000USD | 239,023,000USD |
| Unclassified Non Current Assets | 122,300,000USD | — | 89,500,000USD | — | -5,057,100,000USD | -429,200,000USD | — | — |
| Unclassified Current Liabilities | -99,300,000USD | -101,400,000USD | -181,800,000USD | -62,800,000USD | -60,400,000USD | -64,400,000USD | -56,000,000USD | -55,552,000USD |
| Unclassified Non Current Liabilities | 455,600,000USD | 331,300,000USD | 248,900,000USD | 236,400,000USD | -87,000,000USD | -139,700,000USD | 220,200,000USD | 28,311,000USD |
| Unclassified Equity | 2,539,300,000USD | 2,519,600,000USD | 2,496,300,000USD | 2,476,700,000USD | 1,621,400,000USD | 607,400,000USD | 662,200,000USD | 313,784,000USD |
| Current Deferred Revenue | — | — | 108,500,000USD | 3,200,000USD | 64,400,000USD | 109,800,000USD | -190,000,000USD | -138,844,000USD |
| Short Term Investments | — | — | 74,600,000USD | — | — | 90,000,000USD | — | — |
| Unclassified Current Assets | — | — | -74,600,000USD | — | — | -90,000,000USD | — | — |
| Other Liab | — | — | — | 35,000,000USD | 402,600,000USD | 440,600,000USD | 62,900,000USD | 121,500,000USD |
| Other Assets | — | — | — | 122,300,000USD | 5,171,500,000USD | 554,000,000USD | 129,500,000USD | 146,100,000USD |
| Net Tangible Assets | — | — | — | -1,567,800,000USD | 1,089,000,000USD | -2,357,100,000USD | -3,152,900,000USD | -3,032,500,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -35,900,000USD | 29,000,000USD | 25,300,000USD | 44,900,000USD | -46,600,000USD | 6,400,000USD | -15,500,000USD | 24,300,000USD |
| Depreciation | 38,500,000USD | 59,900,000USD | 39,500,000USD | 40,300,000USD | 33,900,000USD | 50,200,000USD | 34,800,000USD | 33,700,000USD |
| Stock Based Compensation | 5,800,000USD | -2,200,000USD | 2,600,000USD | 6,800,000USD | 6,200,000USD | 7,100,000USD | 15,100,000USD | 4,900,000USD |
| Other Non Cash Items | 52,900,000USD | 21,700,000USD | 29,500,000USD | 7,500,000USD | 28,200,000USD | 27,000,000USD | 79,900,000USD | 13,000,000USD |
| Change To Account Receivables | 3,600,000USD | -46,100,000USD | -16,200,000USD | 3,700,000USD | -40,900,000USD | -19,100,000USD | -17,500,000USD | 5,400,000USD |
| Change In Working Capital | -49,600,000USD | -18,400,000USD | -18,400,000USD | -16,700,000USD | -31,500,000USD | -28,200,000USD | -21,500,000USD | -37,700,000USD |
| Total Cash From Operating Activities | 11,700,000USD | 103,400,000USD | 83,600,000USD | 81,300,000USD | 111,400,000USD | 65,200,000USD | 82,800,000USD | 40,700,000USD |
| Capital Expenditures | -16,000,000USD | -12,800,000USD | -19,800,000USD | -23,400,000USD | -22,300,000USD | -20,200,000USD | -26,900,000USD | -21,000,000USD |
| Free Cash Flow | -4,300,000USD | 90,600,000USD | 63,800,000USD | 57,900,000USD | 89,100,000USD | 45,000,000USD | 55,900,000USD | 19,700,000USD |
| Total Cashflows From Investing Activities | -13,400,000USD | -126,100,000USD | -46,200,000USD | 2,100,000USD | -111,700,000USD | -49,600,000USD | -244,100,000USD | -83,100,000USD |
| Net Borrowings | 1,600,000USD | 113,100,000USD | -33,100,000USD | -11,500,000USD | 95,400,000USD | 33,400,000USD | — | — |
| Total Cash From Financing Activities | -55,900,000USD | 59,200,000USD | -84,100,000USD | -62,600,000USD | 48,000,000USD | -7,300,000USD | 189,600,000USD | 31,700,000USD |
| Change In Cash | -57,600,000USD | 36,500,000USD | -46,700,000USD | 20,800,000USD | 47,700,000USD | 8,300,000USD | 28,300,000USD | -10,700,000USD |
| Begin Period Cash Flow | 239,900,000USD | 203,400,000USD | 250,100,000USD | 229,300,000USD | 221,800,000USD | 213,500,000USD | 185,200,000USD | 195,900,000USD |
| End Period Cash Flow | 182,300,000USD | 239,900,000USD | 203,400,000USD | 250,100,000USD | 269,500,000USD | 221,800,000USD | 213,500,000USD | 185,200,000USD |
| Other Cashflows From Investing Activities | 6,800,000USD | -3,900,000USD | -25,600,000USD | 29,500,000USD | -2,400,000USD | -4,500,000USD | -11,500,000USD | -5,500,000USD |
| Other Cashflows From Financing Activities | -57,099,999USD | -51,400,000USD | -51,000,000USD | -51,100,000USD | -47,400,000USD | -40,700,000USD | -44,800,000USD | -40,600,000USD |
| Unclassified Investing Cash Flow | -4,200,000USD | -109,400,000USD | 45,400,000USD | -6,100,000USD | 24,700,000USD | 24,700,000USD | 38,400,000USD | 26,500,000USD |
| Unclassified Operating Cash Flow | — | 13,400,000USD | 5,100,000USD | -1,500,000USD | 121,200,000USD | 2,700,000USD | -10,000,000USD | 2,500,000USD |
| Unclassified Financing Cash Flow | — | -2,500,000USD | — | — | — | — | 234,400,000USD | 72,300,000USD |
| Investments | — | — | -46,200,000USD | 2,100,000USD | -111,700,000USD | -49,600,000USD | -244,100,000USD | -83,100,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 98,900,000USD | 12,500,000USD | 135,300,000USD | 87,000,000USD | 70,700,000USD | 1,300,000USD | 45,100,000USD | -95,626,000USD |
| Depreciation | 176,000,000USD | 152,600,000USD | 118,100,000USD | 114,800,000USD | 98,800,000USD | 94,800,000USD | 76,500,000USD | 67,440,000USD |
| Stock Based Compensation | 14,800,000USD | 33,300,000USD | 17,700,000USD | 18,400,000USD | 17,400,000USD | 13,200,000USD | 10,200,000USD | 9,344,000USD |
| Other Non Cash Items | 78,300,000USD | 89,100,000USD | 86,700,000USD | 19,000,000USD | 40,400,000USD | 214,800,000USD | 58,000,000USD | 105,009,000USD |
| Change To Account Receivables | -53,800,000USD | -72,100,000USD | -47,200,000USD | -35,300,000USD | -32,100,000USD | -46,600,000USD | -23,500,000USD | -22,819,000USD |
| Change In Working Capital | -110,400,000USD | -118,900,000USD | -62,300,000USD | -102,300,000USD | -149,100,000USD | -55,300,000USD | -68,800,000USD | 33,161,000USD |
| Total Cash From Operating Activities | 274,300,000USD | 300,100,000USD | 293,800,000USD | 158,800,000USD | 87,100,000USD | 246,900,000USD | 129,500,000USD | 144,600,000USD |
| Capital Expenditures | -78,700,000USD | -90,400,000USD | -88,800,000USD | -80,600,000USD | -57,600,000USD | -42,900,000USD | -73,600,000USD | -39,805,000USD |
| Free Cash Flow | 195,600,000USD | 209,700,000USD | 205,000,000USD | 78,200,000USD | 29,500,000USD | 204,000,000USD | 55,900,000USD | 104,795,000USD |
| Total Cashflows From Investing Activities | -246,600,000USD | -488,500,000USD | -225,600,000USD | -307,900,000USD | -331,700,000USD | -88,400,000USD | -85,200,000USD | -128,862,000USD |
| Net Borrowings | 162,800,000USD | 450,400,000USD | 19,500,000USD | -644,200,000USD | -55,500,000USD | 204,600,000USD | 7,200,000USD | 122,164,000USD |
| Total Cash From Financing Activities | -57,300,000USD | 262,000,000USD | -155,200,000USD | 42,100,000USD | 316,300,000USD | 66,700,000USD | -135,900,000USD | -6,300,000USD |
| Change In Cash | -29,600,000USD | 73,600,000USD | -87,000,000USD | -107,000,000USD | 71,700,000USD | 225,200,000USD | -91,600,000USD | 9,394,000USD |
| Begin Period Cash Flow | 269,500,000USD | 195,900,000USD | 282,900,000USD | 389,900,000USD | 318,200,000USD | 93,000,000USD | 184,600,000USD | 175,229,000USD |
| End Period Cash Flow | 239,900,000USD | 269,500,000USD | 195,900,000USD | 282,900,000USD | 389,900,000USD | 318,200,000USD | 93,000,000USD | 184,623,000USD |
| Other Cashflows From Investing Activities | 7,500,000USD | -22,200,000USD | -7,900,000USD | 1,400,000USD | -274,100,000USD | 59,100,000USD | -200,000USD | -1,455,000USD |
| Other Cashflows From Financing Activities | -216,000,000USD | -188,400,000USD | -174,700,000USD | -196,600,000USD | 316,300,000USD | -146,400,000USD | -134,200,000USD | -121,600,000USD |
| Unclassified Operating Cash Flow | 16,700,000USD | 131,500,000USD | — | 21,900,000USD | 8,900,000USD | -21,900,000USD | 8,500,000USD | 25,272,000USD |
| Unclassified Investing Cash Flow | -175,400,000USD | 112,600,000USD | 110,800,000USD | -146,400,000USD | 331,700,000USD | -16,200,000USD | 3,800,000USD | 41,260,000USD |
| Unclassified Financing Cash Flow | -4,100,000USD | — | — | 175,400,000USD | 294,100,000USD | 145,500,000USD | 115,500,000USD | 2,936,000USD |
| Investments | — | -488,500,000USD | -239,700,000USD | -82,300,000USD | -331,700,000USD | -88,400,000USD | -15,200,000USD | -128,862,000USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | 882,900,000USD | 581,800,000USD | 0USD | 0USD | 0USD |
| Dividends Paid | — | — | 0USD | -146,800,000USD | -5,100,000USD | -109,600,000USD | -121,200,000USD | -7,800,000USD |
| Change To Liabilities | — | — | — | 0USD | 0USD | 0USD | 0USD | 0USD |
| Sale Purchase Of Stock | — | — | — | 854,300,000USD | -233,500,000USD | -27,400,000USD | -3,200,000USD | -2,000,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -107,000,000USD | 71,700,000USD | 225,200,000USD | -91,600,000USD | 9,394,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Healthcare Organization Patient Service — Government Revenue | 357,400,000 | USD | 0001638833-26-000046 |
| Q1 2026Quarterly · 2026-03-31 | Product | Healthcare Organization Patient Service — Private Insurance | 398,900,000 | USD | 0001638833-26-000046 |
| Q1 2026Quarterly · 2026-03-31 | Product | Healthcare Organization Patient Service — Self Pay Revenue | 19,200,000 | USD | 0001638833-26-000046 |
| Q1 2026Quarterly · 2026-03-31 | Product | Other Patient Service Revenue Sources | 16,600,000 | USD | 0001638833-26-000046 |
| Q1 2026Quarterly · 2026-03-31 | Product | Other Services | 18,800,000 | USD | 0001638833-26-000046 |
| Q4 2025Quarterly · 2025-12-31 | Product | Healthcare Organization Patient Service — Government Revenue | 356,300,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Healthcare Organization Patient Service — Private Insurance | 473,100,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Healthcare Organization Patient Service — Self Pay Revenue | 19,300,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Other Patient Service Revenue Sources | 16,500,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Other Services | 19,800,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Healthcare Organization Patient Service — Government Revenue | 1,380,300,000 | USD | 0001638833-26-000008 |
| FY 2025Yearly · 2025-12-31 | Product | Healthcare Organization Patient Service — Private Insurance | 1,687,200,000 | USD | 0001638833-26-000008 |
| FY 2025Yearly · 2025-12-31 | Product | Healthcare Organization Patient Service — Self Pay Revenue | 87,600,000 | USD | 0001638833-26-000008 |
| FY 2025Yearly · 2025-12-31 | Product | Other Patient Service Revenue Sources | 71,200,000 | USD | 0001638833-26-000008 |
| FY 2025Yearly · 2025-12-31 | Product | Other Services | 82,400,000 | USD | 0001638833-26-000008 |
| Q3 2025Quarterly · 2025-09-30 | Product | Healthcare Organization Patient Service — Government Revenue | 347,000,000 | USD | 0001638833-25-000163 |
| Q3 2025Quarterly · 2025-09-30 | Product | Healthcare Organization Patient Service — Private Insurance | 404,100,000 | USD | 0001638833-25-000163 |
| Q3 2025Quarterly · 2025-09-30 | Product | Healthcare Organization Patient Service — Self Pay Revenue | 26,500,000 | USD | 0001638833-25-000163 |
| Q3 2025Quarterly · 2025-09-30 | Product | Other Patient Service Revenue Sources | 20,900,000 | USD | 0001638833-25-000163 |
| Q3 2025Quarterly · 2025-09-30 | Product | Other Services | 23,000,000 | USD | 0001638833-25-000163 |
| Q2 2025Quarterly · 2025-06-30 | Product | Healthcare Organization Patient Service — Government Revenue | 348,500,000 | USD | 0001638833-25-000136 |
| Q2 2025Quarterly · 2025-06-30 | Product | Healthcare Organization Patient Service — Private Insurance | 416,200,000 | USD | 0001638833-25-000136 |
| Q2 2025Quarterly · 2025-06-30 | Product | Healthcare Organization Patient Service — Self Pay Revenue | 21,700,000 | USD | 0001638833-25-000136 |
| Q2 2025Quarterly · 2025-06-30 | Product | Other Patient Service Revenue Sources | 17,800,000 | USD | 0001638833-25-000136 |
| Q2 2025Quarterly · 2025-06-30 | Product | Other Services | 22,000,000 | USD | 0001638833-25-000136 |
| Q1 2025Quarterly · 2025-03-31 | Product | Healthcare Organization Patient Service — Government Revenue | 328,500,000 | USD | 0001638833-26-000046 |
| Q1 2025Quarterly · 2025-03-31 | Product | Healthcare Organization Patient Service — Private Insurance | 393,800,000 | USD | 0001638833-26-000046 |
| Q1 2025Quarterly · 2025-03-31 | Product | Healthcare Organization Patient Service — Self Pay Revenue | 20,100,000 | USD | 0001638833-26-000046 |
| Q1 2025Quarterly · 2025-03-31 | Product | Other Patient Service Revenue Sources | 16,000,000 | USD | 0001638833-26-000046 |
| Q1 2025Quarterly · 2025-03-31 | Product | Other Services | 17,600,000 | USD | 0001638833-26-000046 |
| Q4 2024Quarterly · 2024-12-31 | Product | Healthcare Organization Patient Service — Government Revenue | 324,800,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Healthcare Organization Patient Service — Private Insurance | 482,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Healthcare Organization Patient Service — Self Pay Revenue | 22,100,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Other Patient Service Revenue Sources | 18,900,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Other Services | 16,600,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Healthcare Organization Patient Service — Government Revenue | 1,256,800,000 | USD | 0001638833-26-000008 |
| FY 2024Yearly · 2024-12-31 | Product | Healthcare Organization Patient Service — Private Insurance | 1,634,200,000 | USD | 0001638833-26-000008 |
| FY 2024Yearly · 2024-12-31 | Product | Healthcare Organization Patient Service — Self Pay Revenue | 82,300,000 | USD | 0001638833-26-000008 |
| FY 2024Yearly · 2024-12-31 | Product | Other Patient Service Revenue Sources | 81,100,000 | USD | 0001638833-26-000008 |
| FY 2024Yearly · 2024-12-31 | Product | Other Services | 59,900,000 | USD | 0001638833-26-000008 |
| Q3 2024Quarterly · 2024-09-30 | Product | Healthcare Organization Patient Service — Government Revenue | 318,300,000 | USD | 0001638833-25-000163 |
| Q3 2024Quarterly · 2024-09-30 | Product | Healthcare Organization Patient Service — Private Insurance | 393,200,000 | USD | 0001638833-25-000163 |
| Q3 2024Quarterly · 2024-09-30 | Product | Healthcare Organization Patient Service — Self Pay Revenue | 19,700,000 | USD | 0001638833-25-000163 |
| Q3 2024Quarterly · 2024-09-30 | Product | Other Patient Service Revenue Sources | 22,000,000 | USD | 0001638833-25-000163 |
| Q3 2024Quarterly · 2024-09-30 | Product | Other Services | 17,200,000 | USD | 0001638833-25-000163 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Ancillary Services | 35,000,000 | USD | 0001638833-24-000147 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Surgical Facility Services | 735,400,000 | USD | 0001638833-24-000147 |
| Q2 2024Quarterly · 2024-06-30 | Product | Healthcare Organization Patient Service — Government Revenue | 310,100,000 | USD | 0001638833-25-000136 |
| Q2 2024Quarterly · 2024-06-30 | Product | Healthcare Organization Patient Service — Private Insurance | 398,000,000 | USD | 0001638833-25-000136 |
| Q2 2024Quarterly · 2024-06-30 | Product | Healthcare Organization Patient Service — Self Pay Revenue | 20,700,000 | USD | 0001638833-25-000136 |
| Q2 2024Quarterly · 2024-06-30 | Product | Other Patient Service Revenue Sources | 19,300,000 | USD | 0001638833-25-000136 |
| Q2 2024Quarterly · 2024-06-30 | Product | Other Services | 14,000,000 | USD | 0001638833-25-000136 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Ancillary Services | 31,700,000 | USD | 0001638833-24-000135 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Surgical Facility Services | 730,400,000 | USD | 0001638833-24-000135 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Ancillary Services | 24,700,000 | USD | 0001638833-24-000113 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Surgical Facility Services | 692,700,000 | USD | 0001638833-24-000113 |
| FY 2023Yearly · 2023-12-31 | Product | Healthcare Organization Patient Service — Government Revenue | 1,128,100,000 | USD | 0001638833-26-000008 |
| FY 2023Yearly · 2023-12-31 | Product | Healthcare Organization Patient Service — Private Insurance | 1,418,600,000 | USD | 0001638833-26-000008 |
| FY 2023Yearly · 2023-12-31 | Product | Healthcare Organization Patient Service — Self Pay Revenue | 68,100,000 | USD | 0001638833-26-000008 |
| FY 2023Yearly · 2023-12-31 | Product | Other Patient Service Revenue Sources | 85,600,000 | USD | 0001638833-26-000008 |
| FY 2023Yearly · 2023-12-31 | Product | Other Services | 42,900,000 | USD | 0001638833-26-000008 |
| Q4 2023Quarterly · 2023-12-31 | Segment | Ancillary Services | 16,100,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Segment | Surgical Facility Services | 719,300,000 | USD | Legacy provider |
| FY 2023Yearly · 2023-12-31 | Segment | Ancillary Services | 67,500,000 | USD | 0001638833-24-000029 |
| FY 2023Yearly · 2023-12-31 | Segment | Surgical Facility Services | 2,675,800,000 | USD | 0001638833-24-000029 |
| Q3 2023Quarterly · 2023-09-30 | Segment | Ancillary Services | 16,800,000 | USD | 0001638833-24-000147 |
| Q3 2023Quarterly · 2023-09-30 | Segment | Surgical Facility Services | 657,300,000 | USD | 0001638833-24-000147 |
| Q2 2023Quarterly · 2023-06-30 | Segment | Ancillary Services | 17,400,000 | USD | 0001638833-24-000135 |
| Q2 2023Quarterly · 2023-06-30 | Segment | Surgical Facility Services | 650,200,000 | USD | 0001638833-24-000135 |
| Q1 2023Quarterly · 2023-03-31 | Segment | Ancillary Services | 17,200,000 | USD | 0001638833-24-000113 |
| Q1 2023Quarterly · 2023-03-31 | Segment | Surgical Facility Services | 649,000,000 | USD | 0001638833-24-000113 |
| FY 2022Yearly · 2022-12-31 | Product | Healthcare Organization Patient Service — Government Revenue | 1,059,200,000 | USD | 0001638833-25-000053 |
| FY 2022Yearly · 2022-12-31 | Product | Healthcare Organization Patient Service — Private Insurance | 1,288,000,000 | USD | 0001638833-25-000053 |
| FY 2022Yearly · 2022-12-31 | Product | Healthcare Organization Patient Service — Self Pay Revenue | 65,900,000 | USD | 0001638833-25-000053 |
| FY 2022Yearly · 2022-12-31 | Product | Other Patient Service Revenue Sources | 89,000,000 | USD | 0001638833-25-000053 |
| FY 2022Yearly · 2022-12-31 | Product | Other Services | 37,200,000 | USD | 0001638833-25-000053 |
| Q4 2022Quarterly · 2022-12-31 | Segment | Ancillary Services | 17,300,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Segment | Surgical Facility Services | 689,800,000 | USD | Legacy provider |
| FY 2022Yearly · 2022-12-31 | Segment | Ancillary Services | 68,900,000 | USD | 0001638833-23-000021 |
| FY 2022Yearly · 2022-12-31 | Segment | Optical Services | 0 | USD | 0001638833-23-000021 |
| FY 2022Yearly · 2022-12-31 | Segment | Surgical Facility Services | 2,470,400,000 | USD | 0001638833-23-000021 |
| FY 2021Yearly · 2021-12-31 | Product | Healthcare Organization Patient Service — Government Revenue | 949,900,000 | USD | 0001638833-24-000029 |
| FY 2021Yearly · 2021-12-31 | Product | Healthcare Organization Patient Service — Private Insurance | 1,110,100,000 | USD | 0001638833-24-000029 |
| FY 2021Yearly · 2021-12-31 | Product | Healthcare Organization Patient Service — Self Pay Revenue | 61,100,000 | USD | 0001638833-24-000029 |
| FY 2021Yearly · 2021-12-31 | Product | Other Patient Service Revenue Sources | 73,900,000 | USD | 0001638833-24-000029 |
| FY 2021Yearly · 2021-12-31 | Product | Other Services | 30,100,000 | USD | 0001638833-24-000029 |
| FY 2021Yearly · 2021-12-31 | Segment | Ancillary Services | 67,300,000 | USD | 0001638833-23-000021 |
| FY 2021Yearly · 2021-12-31 | Segment | Optical Services | 0 | USD | 0001638833-23-000021 |
| FY 2021Yearly · 2021-12-31 | Segment | Surgical Facility Services | 2,157,800,000 | USD | 0001638833-23-000021 |
| FY 2020Yearly · 2020-12-31 | Product | Healthcare Organization Patient Service — Government Revenue | 708,500,000 | USD | 0001638833-21-000034 |
| FY 2020Yearly · 2020-12-31 | Product | Healthcare Organization Patient Service — Private Insurance | 989,900,000 | USD | 0001638833-21-000034 |
| FY 2020Yearly · 2020-12-31 | Product | Healthcare Organization Patient Service — Self Pay Revenue | 58,500,000 | USD | 0001638833-21-000034 |
| FY 2020Yearly · 2020-12-31 | Product | Optical Services | 3,000,000 | USD | 0001638833-21-000034 |
| FY 2020Yearly · 2020-12-31 | Product | Other Patient Service Revenue Sources | 79,200,000 | USD | 0001638833-21-000034 |
| FY 2020Yearly · 2020-12-31 | Product | Other Services | 21,000,000 | USD | 0001638833-21-000034 |
| FY 2020Yearly · 2020-12-31 | Segment | Ancillary Services | 63,600,000 | USD | 0001638833-23-000021 |
| FY 2020Yearly · 2020-12-31 | Segment | Optical Services | 3,100,000 | USD | 0001638833-23-000021 |
| FY 2020Yearly · 2020-12-31 | Segment | Surgical Facility Services | 1,793,400,000 | USD | 0001638833-23-000021 |
| FY 2019Yearly · 2019-12-31 | Product | Healthcare Organization Patient Service — Government Revenue | 701,900,000 | USD | 0001638833-21-000034 |
| FY 2019Yearly · 2019-12-31 | Product | Healthcare Organization Patient Service — Private Insurance | 970,500,000 | USD | 0001638833-21-000034 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.